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In an infectious poliovirus cDNA construct, the determinant encoding antigenic epitope N-Agl (in a loop located between two B-strands in poly- 
peptide VPl) was altered by site-directed mutagenesis, to be partially similar with the determinants for presumptive pitopes in polypeptides VP1 
or VP3 of hepatitis A virus (HAV). The modified constructs proved to be infectious. However, another construct, in which the same locus encoded 
a ‘nonsense’ and a relatively hydrophobic amino acid sequence, exhibited no infectivity. These data showed the feasibility of the insertion of foreign 
sequences in a specific antigenically active locus of the poliovirus icosahedron, and suggest some limitations with respect to the sequences to be 
‘transplanted’. 
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1. INTRODUCTION 
Hepatitis A virus (HAV) belongs to the Picor- 
naviridae family, which also includes polioviruses and 
numerous other small naked (i.e. lacking a lipoprotein 
membrane) icosahedral animal viruses, with single- 
stranded RNA genome of positive polarity. Since 
hepatitis A is a major medical problem and since no ef- 
ficient anti-HAV vaccine is yet available, several ap- 
proaches to design such vaccines are currently being 
explored. One such approach may consist of introduc- 
ing HAV antigenic determinants into structurally 
related attenuated poliovirus strains (the Sabin strains), 
which have an excellent record as efficient and safe oral 
vaccines. The feasibility of such an approach could be 
demonstrated by the successful construction of 
chimeric polioviruses exhibiting antigenic properties of 
two different serotypes [l-3]. The site of choice for 
manipulating with antigenic determinants in the 
poliovirus particle, is the amino acid sequence from 
positions 93-103 corresponding to a loop between two 
P-strands in the capsid polypeptide VP1 (antigenic site 
N-Agl). Although this site appears to tolerate different 
kinds of substitutions and insertions and the newly in- 
troduced amino acid sequence could be antigenically 
active [l-5], the extent to which the site could be 
modified without an adverse effect on the self-assembly 
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and stability of the viral icosahedron remains 
unknown. Neither is the exact structure of the antigenic 
site of HAV known. 
On the basis of these considerations, we began con- 
struction of a variety of derivatives of the Sabin 
poliovirus strains with antigenic determinants made 
more or less similar with presumptive antigenic deter- 
minants of HAV. Two such derivatives are described 
here. In addition, a cDNA construct, in which the N- 
Ag 1 -coding region was replaced by a biologically irrele- 
vant sequence of the same length, turned out to be non- 
infectious, suggesting that some limitations on the 
structure to be ‘transplanted’ should exist. 
2. MATERIALS AND METHODS 
A full-length cDNA copy of the Sabin type 1 genome was prepared 
by using standard procedures [6]. The first strand was synthesized by 
reverse transcription using oligo(dT)iz_is as primers as well as 
oligodeoxyribonucleotides corresponding to positions 503 l-5050 and 
2421-2440 of the viral genome. The second strand was synthesized 
with the help of E. coli DNA polymerase 1 in the presence of RNase 
H. EcoRI linkers were ligated to virus-specific double-stranded DNA 
fragments followed by the insertion of these fragments into the 
EcoRI site of pBR322. The search for clones with specific inserts was 
accomplished with the help of “P-labeled oligonucleotides. Since the 
5 ‘-terminal sequence was missing from the isolated clones, the ap- 
propriate segment was chemically synthesized (positions 1-33 and 
34-70 of the (+) and l-66 of the (-) strand, respectively); the syn- 
thesized segment had an EcoRI site adjacent to its 5’ terminus and 
a Kpn site at the 3’ terminus. 
For the mutagenesis, a PstI fragment of the Sabin type l-specific 
cDNA, encompassing nucleotides 2245-3419, was cloned into 
M13mplO. The U-containing DNA template was produced by grow- 
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ing the phage in E. co/i RZ1032 cells. The mutagenesis was ac- 
complished with the help of synthetic oligodeoxyribonucleotides as 
described [7]. Mutant clones were selected by the hybridization with 
labeled probes. 
The infectivity of plasmids or their transcripts was assayed using 
7-day-old primary cultures of monkey kidney cells. After removal of 
the media, the cells were incubated for 7 min at room temperature 
with Earle’s saline containing lO@rg/ml of DEAE-dextran. The 
saline was removed and an appropriate dilution of the RNA (or 
DNA) in 0.1 ml of 0.87% NaCl, 0.01 M phosphate, pH 7.1, contain- 
ing 500pg/ml of DEAE-dextran was added. The bottles were in- 
cubated for 15 min at room temperature with permanent gentle 
shaking. The agar overlay was finally added. 
3. RESULTS AND DISCUSSION 
As a first step to our goal, a full length cDNA copy 
of the Sabin type 1 genome was prepared. The plasmid 
(pOLS1) was combined from 5 fragments as outlined in 
fig.1. The virus-specific sequence was recloned into 
plasmid pGEM3 under the control of an SP6 promoter; 
the resulting plasmid was named pPVS. Neither pPVS, 
nor its RNA transcripts were found to be infectious 
when assayed for plaque formation in monkey kidney 
cells. The reason for non-infectivity of pPVS was not 
further investigated, but a new construct was made by 
combining the sequences of pPVS encoding the ap- 
propriate segment of the Sabin type 1 polypeptide VP1 
as well as the SP6 promoter (and adjacent sequences) 
with the remainder virus-specific sequences from an in- 
fectious plasmid pSVp harboring cDNA of a Sabin type 
l-related strain Mahoney (pSVp was kindly provided 
by D. Baltimore). The way by which the new plasmid, 
pPVS-3M, was constructed, is shown in fig.1. Both 
pPVS-3M and its transcript proved to be infectious. 
2 Isolate-2500 bp fragment 
kontamlng and 3’md 
1 Partld SC01 
d gest 
2 kolate-7UBbp 
TL DNA haase 
Mutated fragment 
-r I=‘- ’ 
SP6 Promoter 
SPFPromter 
1 Partial Pstl digest 2 lsolale.6630 bp fragment 3 14 DNA lgase 
Fig.1. Strategies for plasmid construction. Sites for restriction endonucleases Kpnl (K), Eco47111 (E), BglIl (B), EcoRI (R), Seal (S) and pstl 
(p) are shown. pBR322APvulI was derived from pBR322 by the deletion of a short PvuII-EcoRI segment, addition of an EcoRl linker to the 
blunt end and ligation. 
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(A1 “-” 3’ GTACGCACCGGTAATATTGGCACCTATTGAGTCGAAGGTGTGTCAC 
,!+11 5’ CATGCGTGGCCATTATAACCGTGGATAACTCAGCTTCCACCAAGAATAAGGATAAGCTATTTACAGTG 
“aa” ACVAIITVDNSASTKNKDKLFAY 
85 107 
(B1 11-11 GTGGTTgTTATTCCTcTTCGAT 
I,+,, !#lC GAg 
,taa,t N E 
103 106 
(C) 
11_11 ATTGGCACtTAcgGAGTCtAAGGcacccCgTtgTCCTATTCG 
rl+t! aATgcC GaT gtgggGcAacAG 
,laa” N A D V G Q Q 
67 75 
(D) 
11-11 CGCACCGGTAATATTGGCAttgcgTagGctGAgGcaaccagTcgTcCCTATTCGATAAA 
,r+tt aacgcAtcCgaCTcCgttggtcAgcAgG 
t’aa” THPTPLVSW 
Fig.2. Oligonucleotides used for mutagenesis, and amino acid changes produced. The primary structure of a segment of the Sabin 1 gene for 
VP1 is shown in (A). Derivation of plasmids pPVS-3M-HAV2, pPVS-3M-HAV7 and pPVS-3M-HAVN are given in (B), (C) and (D), respectively. 
The primary structures of the appropriate segment of Sabin-1 (- )DNA strand (A) and of the oligonucleotides used for mutagenesis (B-D) are 
shown in lines ’ - ‘. The primary structures of the (+ )DNA strands and of proteins are shown in lines ‘ + ’ and ‘aa’, respectively. The mutated 
nucleotides are shown in lower case letters. Only the changed codons and amino acids are indicated in the mutated plasmids. The amino acid 
numbering in (B) and (C) is given for HAV VP1 and VP3, respectively. 
Then, we attempted to introduce into the N-Agl 
coding segment of pPVS3M some alterations which 
should make this antigenic site partially similar to 
presumptive antigenically active sites in the HAV VP1 
or VP3 [6,8]. Plasmid pPVS-3M-HAV2 was con- 
structed in such a way as to encode an HAV 
VP 1 -specific amino acid sequence (positions 103- 106) 
instead of the poliovirus-specific sequence in positions 
99-102. To do this, only 2 nucleotide changes should 
be made, with 2 codons being altered (fig.2). The se- 
cond plasmid, pPVS-3M-HAV7, could code for amino 
acid positions 67-75 of HAV VP3 (instead of 
poliovirus VP1 positions 93-101). This required 7 
codons to be mutated (fig.2). The mutagenesis was car- 
ried out first in a virus-specific DNA segment cloned in 
M13mplO and then full-length plasmids were restored 
as shown in fig.1. 
The infectivity assays with plasmids pPVS-3M- 
HAV2 (having substitutions resembling the appropriate 
site in HAV VPl) and pPVS-3M-HAV7 (substitutions 
resembling the site in HAV VP3) showed both of them 
as being infectious. Thus, our results support the 
feasibility of alterations of the N-Agl site in poliovirus 
VP1 as a tool for creating novel virus variants. The an- 
tigenic and serological properties of pPVS-3M-HAV2 
and pPVS-3M-HAV7 are being investigated. 
Although the genomic region we are manipulating 
could be changed in various ways, some alterations ap- 
peared to be prohibited. Thus, plasmid pPVS-3M- 
HAVN, which encoded a biologically irrelevant peptide 
in positions 99-107 (due to a local frame shift), ex- 
hibited no infectivity. It could be supposed that the 
lethal phenotype of this construct was due to relative 
hydrophobicity of the inserted sequence. Although it is 
yet to be rigorously proved that non-viability of 
pPVS-3M-HAVN could be explained solely by the in- 
tentionally introduced genomic alterations, possible 
limitations for the design of artificial viable viruses 
should be taken into account. 
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